ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

New Publications

January 20, 1989

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

13th Congress Advance Program Announcement Now Available

May 1, 1981

‘Interactive Research Project Grants’ Proposed, Goal To Provide Step Between R01s and P01s

October 25, 1991

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007

Univ. Of Washington, Fox Chase, ICC Win CCRU, CCSP Awards

July 8, 1983